Pluton Biosciences Founder Dr. Barry Goldman Assumes Chief Executive Officer Position
St. Louis, MO, USA - April 13, 2021
Pluton Biosciences is proud to announce that its founder Dr. Barry Goldman, PhD, has assumed the role of Chief Executive Officer.
Pluton Biosciences Signs Research Agreement with Bayer AG to Investigate Microbial-Based Carbon Capture Product
St. Louis, MO, USA - March 2, 2021
Pluton Biosciences has signed a research agreement with global life sciences company Bayer AG to investigate the development of an all-natural, microbial-based carbon-capture soil amendment for growers.
Pluton Biosciences Accepted into Plug and Play Agtech Accelerator
St. Louis, MO, USA - February 18, 2021
St. Louis-based biotech company Pluton Biosciences proudly announces its acceptance into Plug and Play Tech Center’s (Plug and Play) agtech accelerator program.
Pluton Biosciences First St. Louis-Based Biotech Company to Graduate from Global Funding Cycle of Illumina Accelerator
St. Louis, MO, USA - February 10, 2021
Pluton Biosciences is proud to announce that it is the first St. Louis-based biotech company to graduate from Illumina Accelerator’s first global funding cycle and 11th U.S. cycle.
Pluton Biosciences CEO Charlie Walch to Participate in Ag Innovation Roundtable as Part of STL Startup Week
St. Louis, MO, USA - November 6, 2020
Pluton Biosciences CEO Charlie Walch will join next week’s Ag Innovation roundtable as part of STL Startup Week. The second annual STL Startup Week offers an extended lineup of online workshops and special events designed for idea-thinkers, innovators, researchers, investors, entrepreneurs, and small business owners to connect, learn, and grow their businesses.
Pluton Biosciences Expands with Addition of Two Research Associates
St. Louis, MO, USA - October 2, 2020
Pluton Biosciences has expanded its team to include two new Research Associates, Elizabeth Scherer and Farhan William. Pluton is a microbial testing and discovery research company based in St. Louis dedicated to finding unique microbes in the soil for use in sustainable, natural products. Pluton’s first product candidates are ten novel bacteria capable of eliminating larvae of disease-carrying mosquitoes.
Pluton Biosciences Launches New Website Highlighting Microbial Testing Division Microbe Inotech
St. Louis, MO, USA - September 22, 2020
Pluton Biosciences is pleased to announce that it has launched a new website, branding and updated services for its microbial testing division, Microbe Inotech Laboratories (MiL). Pluton Biosciences acquired the 29-year-old laboratory, which provides environmental pathogen testing and identification, at the start of 2020.
Pluton Biosciences First St. Louis-based Biotech Company Selected for Global Illumina Accelerator
St. Louis, MO, USA - June 26, 2020
Pluton Biosciences is the first St. Louis-based biotech company to be chosen for Illumina Accelerator, a company creation engine started by San Diego-based, global DNA sequencing leader Illumina, Inc. (NASDAQ: ILMN).
Pluton Biosciences Selected for Wells Fargo Innovation Incubator
St. Louis, MO, USA - May 21, 2020
The Wells Fargo Innovation Incubator (IN2), a technology incubator and platform funded by the Wells Fargo Foundation and co-administered by the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL), today announced that it has selected Pluton Biosciences to join the program as a member of IN2’s seventh cohort.
Pluton Biosciences, Evolugate Enter License Agreement to Advance Bacterial Strains for Commercial Biopesticide Development
St. Louis, MO, USA - May 13, 2020
Pluton Biosciences, Inc. is pleased to announce that it has entered into an exclusive license agreement with biotechnology company Evolugate of Gainesville, FL to optimize its mosquito biopesticide discovery for commercial use in the vector control industry.
Pluton's Testing Lab Microbe Inotech Not Disrupted by COVID-19
St. Louis, MO, USA - March 19, 2020
Pluton's Testing Division Microbe Inotech (MiL) is committed to remaining open and providing lab testing services for the duration of the Coronavirus pandemic in the United States. As a provider of food, water and environmental safety tests for microbial pathogens, we anticipate qualifying as a “vital industry” to remain open should a “shelter-in-place” order be issued in St. Louis, our lab’s location.
St. Louis Startup Pluton Biosciences Acquires Microbe Inotech Laboratories, Inc.
St. Louis, MO, USA - February 20, 2020
St. Louis startup Pluton Biosciences, Inc. is pleased to announce that it has acquired Microbe Inotech Laboratories (MiL), Inc., a full-service microbiological lab also headquartered in St. Louis. The 29-year-old laboratory is now Pluton MiL, LLC, a division of Pluton Biosciences.
Pluton Biosciences Launches Crowdfunding Campaign Through Nvsted
St. Louis, MO, USA - January 11, 2019
St. Louis-based Pluton Biosciences launched today a new investment offering through local crowdfunding platform Nvsted. Pluton is also seeking to raise additional funds from accredited investors through a separate Regulation D offering. Together, the offerings will propel the biosciences startup beyond its first major discovery toward its goal of becoming a global leader in assay-based microbial research and discovery.
Pluton Biosciences Signs Research and License Agreement with Terramera
St. Louis, MO, USA - October 2, 2018
St. Louis Based Pluton Biosciences Signs Research and License Agreement with Terramera to Test Novel Discoveries Using Bacteria for Insect Control.
Pluton Biosciences – Micromining Explained
St. Louis, MO, USA - August 16, 2018
Pluton Biosciences – Micromining Explained